using lineage tracing to define responding car t-cells in patients with lbcl
Published 2 months ago • 79 plays • Length 2:09Download video MP4
Download video MP3
Similar videos
-
1:06
car-t cell therapy: current applications and how to improve treatment strategies in the future
-
1:49
car-t cell approaches in cll: current progress & future directions
-
3:14
using machine learning to identify trajectories of hematotoxicity following car t-cell therapy
-
3:52
updates on the use of car-t therapy for the treatment of dlbcl in the second-line setting
-
3:18
evaluating dual-targeting cd19/22 car-t cells in patients with r/r all
-
14:17
biol 430 lab 11 microtiter plate assay analysis howto
-
3:39
adaptimmune's allogeneic or 'off-the-shelf' cell therapies.
-
1:43
cone beam ct imaging with the morita veraview x800
-
1:39
the role of myeloid cells in car-t cell therapy
-
3:27
using ai to predict patient response to car-t cell therapy: analysis of the juliet trial
-
1:55
exploring first-line car-t therapy for the treatment of dlbcl
-
6:46
an overview of car t-cell therapies in the treatment of patients with mcl
-
0:38
the functional role of cd4- and cd8-expressing t-cells in aml
-
0:50
the practical challenges of using novel car t-cell agents
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
1:02
the use of car-t cell products in a real-world setting
-
0:43
developing an avidcar platform to improve t-cell activity
-
2:49
identifying novel antigens for tcr t-cell therapy
-
1:42
challenges associated with car-t cell production
-
2:05
the cost-effectiveness of car t-cell therapy